Literature DB >> 17449723

The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling.

Frederick J Sheedy1, Luke A J O'Neill.   

Abstract

Signaling by two of the most important bacteria-sensing TLRs, TLR2 and TLR4, involves two adaptor proteins, MyD88 adaptor-like (Mal) and Toll/IL-1 receptor (TIR) domain-containing adaptor-inducing IFN-beta (Trif)-related adaptor molecule (TRAM). Recently, new insights into the functioning of these two adapters have emerged. Mal is required by both TLRs to act as a bridge to recruit the adaptor MyD88, leading ultimately to NF-kappaB activation. Similarly, TRAM acts as a bridge to recruit TRIF to the TLR4 complex, leading to activation of the transcription factor IFN regulatory factor 3. Consistent with Mal and TRAM being key points of control, recent evidence suggests that they are subject to regulation by phosphorylation. Further, a variant in Mal in humans has been found to protect against multiple infectious diseases. Finally, another TIR domain-containing adaptor, sterile alpha and HEAT/armadillo motif protein (SARM), has been shown to act as an inhibitor of TRIF-dependent signaling. These recent discoveries add to the complexity of TLR signaling and highlight specific control mechanisms for TLR2 and TLR4 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17449723     DOI: 10.1189/jlb.1206750

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  16 in total

1.  Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM.

Authors:  Lijian Wang; Estela Trebicka; Ying Fu; Lisa Waggoner; Shizuo Akira; Katherine A Fitzgerald; Jonathan C Kagan; Bobby J Cherayil
Journal:  J Innate Immun       Date:  2011-04-14       Impact factor: 7.349

2.  Contrasting ocular effects of local versus systemic endotoxin.

Authors:  James T Rosenbaum; April Woods; Jelena Kezic; Stephen R Planck; Holly L Rosenzweig
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-17       Impact factor: 4.799

3.  Toll-like receptors mediated signalings: friends or enemies?

Authors:  Yan Zhang
Journal:  Dig Dis Sci       Date:  2013-10       Impact factor: 3.199

4.  TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.

Authors:  Anguo Liu; Ping Gong; Sang W Hyun; Kent Z Q Wang; Elizabeth A Cates; Darren Perkins; Douglas D Bannerman; Adam C Puché; Vladimir Y Toshchakov; Shengyun Fang; Philip E Auron; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

5.  OM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells.

Authors:  Hong Luan; Qian Zhang; Le Wang; Chuanxiao Wang; Miao Zhang; Xiaoli Xu; Huan Zhou; Xing'ai Li; Qing Xu; Fan He; Jin Yuan; Yongman Lv
Journal:  J Interferon Cytokine Res       Date:  2014-03-07       Impact factor: 2.607

Review 6.  The role of iron in the immune response to bacterial infection.

Authors:  Bobby J Cherayil
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

7.  Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes.

Authors:  Romi Ghose; Tao Guo; Jesus G Vallejo; Adarsh Gandhi
Journal:  Drug Metab Dispos       Date:  2011-02-08       Impact factor: 3.922

8.  Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance.

Authors:  Wenji Piao; Chang Song; Haiyan Chen; Larry M Wahl; Katherine A Fitzgerald; Luke A O'Neill; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

9.  The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation.

Authors:  Jianhui Ma; Bo-Ram Bang; Jiawei Lu; So-Young Eun; Motoyuki Otsuka; Michael Croft; Peter Tobias; Jiahuai Han; Osamu Takeuchi; Shizuo Akira; Michael Karin; Hideo Yagita; Young Jun Kang
Journal:  Sci Signal       Date:  2013-10-01       Impact factor: 8.192

10.  The CO donor CORM-2 inhibits LPS-induced vascular cell adhesion molecule-1 expression and leukocyte adhesion in human rheumatoid synovial fibroblasts.

Authors:  Pei-Ling Chi; Yu-Chen Chuang; Yu-Wen Chen; Chih-Chung Lin; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.